CClinicalTrials.gg
Status unknownNCT04366700Updated May 5, 2020

Evaluate the Effect of Graft and Membrane on Healing of Apicomarginal Defects

An interventional study of Periapical surgery with autograft and collagen membrane and Periapical surgery with collagen membrane in Apicomarginal Defects, sponsored by Postgraduate Institute of Dental Sciences Rohtak. Status unknown at 1 site in India. Open to participants aged 16 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-05.

Sponsored by Postgraduate Institute of Dental Sciences Rohtak · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2020), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Nov 2018, registered Apr 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
16 Years to 55 Years
Sex
All
01

Study summary

This study will compare the effect of guided tissue regeneration using a mixture of autograft and PRF covered with a collagen membrane as compared to the membrane alone in the healing of apicomarginal defects. Healing of the lesions will be compared 2 dimensionaly and 3 dimensionaly using CBCT.

Read the detailed description

Patients with apicomarginal defects as per the inclusion criteria will be randomly divided into two groups -in test group 1 -the defects will be filled with a mixture of autograft(which will be obtained from the surrounding buccal cortical plate by using a trephine bur) and prf(will be prepared by Choukron's method) and the defects and denuded root surface will be covered with a collagen membrane and in test group 2 -the defects will be filled with a blood clot and over that the collagen membrane will be placed. Radiographic and clinical healing will be assessed after 12 months, 2D healing will be assessed by Rud and Molven criteria and 3D healing will be assessed by Modified Penn 3D criteria.The clinical parameters recorded including periodontal pocket depth (PD), clinical attachment level (CAL) and gingival margin position (GMP) and will be measured on buccal aspect of the interproximal space and mid buccal aspect of the involved teeth using Williams 'O' periodontal probe.Routine examination procedure will be used to evaluate any evidence of signs and/or symptoms.. The criteria for a successful outcome included the absence of clinical signs and/or symptoms and radiographic evidence of complete or incomplete healing.

02

Conditions studied

  • Apicomarginal Defects

Keywords

  • apicomarginal defects
  • autograft
  • prf
  • collagen membrane
03

In context

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak is the lead sponsor of 209 studies on the registry; 71 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with age 16 years to 55 years
  • Periapical defects with periodontal communication.
  • Apicomarginal defects with probing depth > 6mm on mid-buccal and interproximal surfaces

Exclusion criteria

Exclusion criteria

  • Presence of buccal bone on flap elevation.
  • Fractured /perforated roots.
  • smokers.
  • pregnant females and lactating mothers
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Bone replacement substitute and membrane

    periapical surgery will be done and defect will be filled with a mixture of autograft and prf and over the defect and denuded root surface collagen membrane will be placed before closure of flap

    Procedure: Periapical surgery with autograft and collagen membrane

  • Active comparator
    membrane

    periapical surgery will be done and defect will be filled with blood clot and over the defect and denuded root surface collagen membrane will be placed before closure of flap

    Procedure: Periapical surgery with collagen membrane

Interventions

  • ProcedurePeriapical surgery with autograft and collagen membrane

    periapical surgery will be done and the defects will be filled with a mixture of autograft and prf and will be covered with a collagen membrane

  • ProcedurePeriapical surgery with collagen membrane

    periapical surgery will be done and the defects will be filled with blood clot and covered with a collagen membrane

06

What researchers measure

Primary outcomes

  1. change from baseline in periapical radiolucency at 12 months

    2 blinded caliberated operators will score the periapical radiolucency at baseline and 12 months by following scoring scores for 2D healing Score1-Complete healing defined by re-establishment of the lamina dura Score 2- Incomplete healing (scar tissue) Score 3- Uncertain healing Score 4- Unsatisfactory healing scores for 3D healing Score1- Complete healing Score 2- Limited healing Score 3- Uncertain healing Score 4- Unsatisfactory healing

    Time frame: Baseline to 12 months

Secondary outcomes

  1. Clinical success

    Clinical success will be assessed by absence of clinical signs and symptoms

    Time frame: Baseline to 12 months

07

Study locations

1 site
  • Post Graduate Institute of Dental Science
    Rohtak, Haryana 124001, India
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04366700
Lead sponsor
Postgraduate Institute of Dental Sciences Rohtak
Responsible party
Sponsor
First posted
Apr 29, 2020
Start date
Nov 1, 2018
Primary completion
Sep 2020 (estimated)
Completion
Sep 2020 (estimated)
Last update
May 5, 2020

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion